These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35481672)

  • 21. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil.
    Leung C; Su L; Simões E Silva AC
    Int J Epidemiol; 2022 Dec; 51(6):1733-1744. PubMed ID: 35947762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for severe COVID-19 infection in Brazilian children.
    Hendler JV; Miranda do Lago P; Müller GC; Santana JC; Piva JP; Daudt LE
    Braz J Infect Dis; 2021; 25(6):101650. PubMed ID: 34774486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and COVID-19 in-hospital fatality in southern Brazil: impact by age and skin color.
    Houvèssou GM; Leventhal DGP; Silva EVD
    Rev Saude Publica; 2022; 56():4. PubMed ID: 35239926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.
    Sorg AL; Hufnagel M; Doenhardt M; Diffloth N; Schroten H; von Kries R; Berner R; Armann J
    Eur J Pediatr; 2022 Oct; 181(10):3635-3643. PubMed ID: 35962242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.
    Kompaniyets L; Agathis NT; Nelson JM; Preston LE; Ko JY; Belay B; Pennington AF; Danielson ML; DeSisto CL; Chevinsky JR; Schieber LZ; Yusuf H; Baggs J; Mac Kenzie WR; Wong KK; Boehmer TK; Gundlapalli AV; Goodman AB
    JAMA Netw Open; 2021 Jun; 4(6):e2111182. PubMed ID: 34097050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.
    Ranzani OT; Bastos LSL; Gelli JGM; Marchesi JF; Baião F; Hamacher S; Bozza FA
    Lancet Respir Med; 2021 Apr; 9(4):407-418. PubMed ID: 33460571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric inflammatory multisystemic syndrome in Brazil: sociodemographic characteristics and risk factors to death.
    Barros LAF; Oliveira VDS; Morais WJ; Dias LA; Almeida JP; Soares MB; Aquino EC; Pinto RM
    J Pediatr (Rio J); 2023; 99(1):31-37. PubMed ID: 35679884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Vera-Zertuche JM; Mancilla-Galindo J; Tlalpa-Prisco M; Aguilar-Alonso P; Aguirre-García MM; Segura-Badilla O; Lazcano-Hernández M; Rocha-González HI; Navarro-Cruz AR; Kammar-García A; Vidal-Mayo JJ
    Epidemiol Infect; 2021 Apr; 149():e109. PubMed ID: 33913410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 31. Age, gender, and 11 comorbidities as risk factors associated with COVID-19 mortality: A retrospective cohort including 1.8 million individuals.
    Cruz JC; Martins CK; Katchborian Neto A; de Araújo CM; Dellalibera-Joviliano R; Barbosa F
    J Toxicol Environ Health A; 2023 Jul; 86(14):491-500. PubMed ID: 37318302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities.
    Sousa BLA; Sampaio-Carneiro M; de Carvalho WB; Silva CA; Ferraro AA
    Clinics (Sao Paulo); 2020; 75():e2273. PubMed ID: 33263633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With COVID-19 Disease Severity in US Children and Adolescents.
    Antoon JW; Grijalva CG; Thurm C; Richardson T; Spaulding AB; Teufel RJ; Reyes MA; Shah SS; Burns JE; Kenyon CC; Hersh AL; Williams DJ
    J Hosp Med; 2021 Oct; 16(10):603-610. PubMed ID: 34613896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil.
    Leung C; Su L; Simões-E-Silva AC; Arocha LS; de Paiva KM; Haas P
    Emerg Infect Dis; 2023 Jan; 29(1):26-35. PubMed ID: 36573520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
    Tomasoni D; Inciardi RM; Lombardi CM; Tedino C; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Volterrani M; Zaccone G; Guazzi M; Senni M; Metra M
    Eur J Heart Fail; 2020 Dec; 22(12):2238-2247. PubMed ID: 33179839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020.
    Drouin O; Hepburn CM; Farrar DS; Baerg K; Chan K; Cyr C; Donner EJ; Embree JE; Farrell C; Forgie S; Giroux R; Kang KT; King M; Laffin M; Luu TM; Orkin J; Papenburg J; Pound CM; Price VE; Purewal R; Sadarangani M; Salvadori MI; Top KA; Viel-Thériault I; Kakkar F; Morris SK;
    CMAJ; 2021 Sep; 193(38):E1483-E1493. PubMed ID: 34580141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19.
    Seiglie J; Platt J; Cromer SJ; Bunda B; Foulkes AS; Bassett IV; Hsu J; Meigs JB; Leong A; Putman MS; Triant VA; Wexler DJ; Manne-Goehler J
    Diabetes Care; 2020 Dec; 43(12):2938-2944. PubMed ID: 32847827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage.
    Oliveira EA; Simões E Silva AC; Oliveira MCL; Colosimo EA; Mak RH; Vasconcelos MA; Miranda DM; Martelli DB; Silva LR; Pinhati CC; Martelli-Júnior H
    J Pediatr; 2022 May; 244():178-185.e3. PubMed ID: 35031347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidities that predict acute respiratory syndrome coronavirus 2 test positivity in Mexican Children: A case-control study.
    Hernández-Garduño E
    Pediatr Obes; 2021 May; 16(5):e12740. PubMed ID: 33040467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.